Delivery Order SPE2DB22D3301-SPE2DB25FZ1CM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,161.76 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on September 2, 2025, with completion scheduled for September 23, 2025. This competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Kineret (anakinra) is a recombinant human interleukin-1 receptor antagonist used to treat inflammatory conditions, representing...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. The contract is valued at $3,580.88 with a firm fixed price structure and an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Kineret (anakinra) 100 mg/0.67 mL syringes totaling $3,580.88 on July 31, 2025, with an ultimate completion date of August 21, 2025. This non-set-aside, firm fixed-price delivery order represents a pediatric or adult rheumatoid arthritis therapeutic supply under a competitive procurement process. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $3,580.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. This non-set-aside contract is scheduled for completion by September 9, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, will fulfill this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,685.66 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be completed by August 28, 2025, with the contract issued on August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,323.52 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on July 23, 2025, with completion expected by August 13, 2025. This is a firm fixed-price delivery order issued under a competitively awarded indefinite delivery contract. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award reflects no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a $4,476.10 delivery order to AmerisourceBergen Drug Corp for Kineret 100 mg/0.67 mL syringes on June 5, 2025, with an ultimate completion date of June 27, 2025. This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Kineret 100 mg/0.67 mL syringes with a ceiling value of $4,476.10 under a firm fixed-price contract. The order is scheduled for completion by September 15, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order that reflects the standard procurement approach used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes on June 20, 2025, with a ceiling value of $3,580.88 and an ultimate completion date of July 14, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed price pricing and is executed from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Kineret 100 mg/0.67 mL syringes with a ceiling value of $11,637.86 under a firm fixed price arrangement. This delivery order, which is a child contract under AmerisourceBergen's larger pharmaceutical supply agreement, will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. The award...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1CMDelivery Order
The Defense Logistics Agency (DLA) awarded a $10,742.64 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. Kineret (anakinra) is a recombinant interleukin-1 receptor antagonist used to treat rheumatoid arthritis and other inflammatory conditions. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 8, 2025, and will be performed at the company's location in Conshohocken, Pennsylvania. This award was competitively awarded without a set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement standards. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. This master contract vehicle enables the company to supply a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, branded and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with this particular order exemplifying the routine fulfillment of specialized medical commodities necessary for military personnel and veteran care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 9/17/25 |